Wells Fargo’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.9M Sell
74,342
-87,214
-54% -$5.54M ﹤0.01% 2614
2025
Q4
$10.3M Buy
161,556
+64,096
+66% +$3.99M ﹤0.01% 2022
2025
Q3
$5.36M Buy
97,460
+2,110
+2% +$86.9K ﹤0.01% 2509
2025
Q2
$3.15M Buy
95,350
+21,384
+29% +$744K ﹤0.01% 2832
2025
Q1
$2.97M Buy
73,966
+184
+0.2% +$8.46K ﹤0.01% 2847
2024
Q4
$3.47M Buy
73,782
+16,248
+28% +$844K ﹤0.01% 2751
2024
Q3
$3.04M Buy
57,534
+3,426
+6% +$191K ﹤0.01% 2744
2024
Q2
$2.93M Buy
54,108
+13,444
+33% +$811K ﹤0.01% 2666
2024
Q1
$2.85M Buy
40,664
+3,830
+10% +$296K ﹤0.01% 2695
2023
Q4
$3.08M Sell
36,834
-47,596
-56% -$1.72M ﹤0.01% 2566
2023
Q3
$2.49M Sell
84,430
-18,234
-18% -$607K ﹤0.01% 2632
2023
Q2
$3.35M Buy
102,664
+29,193
+40% +$1.08M ﹤0.01% 2482
2023
Q1
$2.59M Buy
73,471
+48,592
+195% +$1.98M ﹤0.01% 2658
2022
Q4
$1.14M Buy
24,879
+1,117
+5% +$48.1K ﹤0.01% 3169
2022
Q3
$1.15M Sell
23,762
-735
-3% -$35.4K ﹤0.01% 3143
2022
Q2
$963K Sell
24,497
-84,324
-77% -$3.39M ﹤0.01% 3313
2022
Q1
$4.01M Sell
108,821
-9,555
-8% -$340K ﹤0.01% 2648
2021
Q4
$5.4M Buy
118,376
+35,643
+43% +$1.38M ﹤0.01% 2494
2021
Q3
$2.96M Buy
82,733
+39,699
+92% +$1.17M ﹤0.01% 3336
2021
Q2
$852K Sell
43,034
-39,024
-48% -$916K ﹤0.01% 4311
2021
Q1
$1.91M Sell
82,058
-75,844
-48% -$1.62M ﹤0.01% 3742
2020
Q4
$3.28M Buy
157,902
+34,442
+28% +$629K ﹤0.01% 3107
2020
Q3
$2.67M Sell
123,460
-8,624
-7% -$202K ﹤0.01% 3075
2020
Q2
$3.11M Buy
132,084
+9,653
+8% +$181K ﹤0.01% 2897
2020
Q1
$1.44M Sell
122,431
-833
-0.7% -$10.6K ﹤0.01% 3274
2019
Q4
$1.31M Buy
123,264
+18,879
+18% +$194K ﹤0.01% 3668
2019
Q3
$1.19M Buy
104,385
+14,828
+17% +$186K ﹤0.01% 3708
2019
Q2
$1.01M Buy
89,557
+60,829
+212% +$587K ﹤0.01% 3860
2019
Q1
$232K Buy
28,728
+223
+0.8% +$1.64K ﹤0.01% 4745
2018
Q4
$180K Buy
28,505
+371
+1% +$2.72K ﹤0.01% 4984
2018
Q3
$277K Buy
28,134
+1,931
+7% +$15.5K ﹤0.01% 4828
2018
Q2
$217K Sell
26,203
-44,953
-63% -$374K ﹤0.01% 4985
2018
Q1
$512K Sell
71,156
-1,091
-2% -$9.35K ﹤0.01% 4366
2017
Q4
$589K Buy
72,247
+21,724
+43% +$247K ﹤0.01% 4271
2017
Q3
$733K Buy
50,523
+16,555
+49% +$226K ﹤0.01% 4070
2017
Q2
$411K Sell
33,968
-5,340
-14% -$74.2K ﹤0.01% 4343
2017
Q1
$505K Buy
39,308
+12,542
+47% +$147K ﹤0.01% 4230
2016
Q4
$325K Buy
26,766
+11,139
+71% +$118K ﹤0.01% 4483
2016
Q3
$144K Buy
15,627
+760
+5% +$7.93K ﹤0.01% 4674
2016
Q2
$141K Sell
14,867
-43,983
-75% -$361K ﹤0.01% 4608
2016
Q1
$415K Buy
58,850
+1,426
+2% +$10.4K ﹤0.01% 3984
2015
Q4
$601K Sell
57,424
-9,650
-14% -$94.6K ﹤0.01% 3808
2015
Q3
$449K Buy
67,074
+2,497
+4% +$17K ﹤0.01% 4005
2015
Q2
$434K Buy
64,577
+12,903
+25% +$84.6K ﹤0.01% 4178
2015
Q1
$350K Buy
51,674
+45,224
+701% +$338K ﹤0.01% 4146
2014
Q4
$51K Buy
6,450
+1,958
+44% +$8.4K ﹤0.01% 5005
2014
Q3
$16K Sell
4,492
-31,110
-87% -$131K ﹤0.01% 5394
2014
Q2
$170K Sell
35,602
-18,538
-34% -$113K ﹤0.01% 4443
2014
Q1
$515K Buy
54,140
+53,140
+5,314% +$481K ﹤0.01% 3855
2013
Q4
$6K Hold
1,000
﹤0.01% 5304
2013
Q3
$8K Buy
+1,000
New +$10.7K ﹤0.01% 5176

Other funds holding CYTK